Generation of Disease-free iPS Cells from Fanconi Anemia Mice with a Hypomorphic Mutation in Brca2

被引：0
|
作者：
Moleiro, V. [1 ,2 ]
Navarro, S. [1 ,2 ]
Lozano, M. L. [1 ,2 ]
Chinchon, R. [1 ,2 ]
Almarza, E. [1 ,2 ]
Quintana-Bustamante, O. [1 ,2 ]
Rio, P. [1 ,2 ]
Mostoslavsky, G. [6 ]
Maetzig, T. [3 ]
Schiedlmeier, B. [3 ]
Modlich, U. [3 ]
Galla, M. [3 ]
Samper, E. [5 ]
Segovia, J. C. [1 ,2 ]
Raya, A. [7 ]
Gueenechea, G. [1 ,2 ]
Baum, C. [3 ]
Izpisua-Belmonte, J. C. [4 ,8 ]
Bueren, J. A. [1 ,2 ]
机构：
[1] Ctr Invest Energet Medioambientales & Tecnol CIEM, Hematopoiet Gene Therapy Div, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
[3] Hannover Med Sch, Inst Expt Hematol, D-3000 Hannover, Germany
[4] Ctr Regenerat Med Barcelona, Barcelona, Spain
[5] Fdn Ctr Nacl Invest Cardiovasc Carlos III, Dept Regenerat Cardiol, Madrid, Spain
[6] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA
[7] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain
[8] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA
来源：
HUMAN GENE THERAPY | 2012年 / 23卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A41 / A41
页数：1
相关论文
共 50 条
  • [31] Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study
    Mikropoulos, Christos
    Castro, Elena
    Bancroft, Elizabeth
    Page, Elizabeth
    Taylor, Natalie
    Ahmed, Mahbubl
    Goh, Chee Leng
    Eeles, Ros A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [32] Rapid and Nuclease-Free Generation of Gene-Repaired Human iPS Cells from IL2RG-Defective Fibroblasts
    Mitani, Ko
    Ohta, Naoyuki
    Nihashi, Nozomu
    Iweanaga, Yuzuru
    Ohtaka, Manami
    Nishimura, Ken
    Nakanishi, Mahito
    MOLECULAR THERAPY, 2015, 23 : S225 - S225
  • [33] Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
    Cagnan, Ilgin
    Gunel-Ozcan, Aysen
    Aerts-Kaya, Fatima
    Ameziane, Najim
    Kuskonmaz, Baris
    Dorsman, Josephine
    Gumruk, Fatma
    Uckan, Duygu
    STEM CELL REVIEWS AND REPORTS, 2018, 14 (03) : 425 - 437
  • [34] Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production
    Ilgin Cagnan
    Aysen Gunel-Ozcan
    Fatima Aerts-Kaya
    Najim Ameziane
    Baris Kuskonmaz
    Josephine Dorsman
    Fatma Gumruk
    Duygu Uckan
    Stem Cell Reviews and Reports, 2018, 14 : 425 - 437
  • [35] Early-onset primary peritoneal carcinoma from atypical cells after risk-reducing salpingo-oophorectomy for BRCA2 mutation carrier: a case report
    Hanako Shimizu
    Tetsuya Ishikawa
    Chiaki Iitsuka
    Mayumi Homma
    Masafumi Takimoto
    Akihiko Sekizawa
    International Cancer Conference Journal, 2017, 6 (3) : 104 - 108
  • [36] Disease-Specifi c Induced Pluripotent Stem (iPS) Cells Derived from the Endometrium of a Patient with HRPT2 Germline Mutation.
    Wolff, Erin Foran
    Wu, Chuanfeng
    Hong, So Gun
    Winker, Thomas
    Tisdale, John
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 111A - 111A
  • [37] Generation of Disease-specific Human Induced Pluripotent Stem (iPS) Cells from Dental Pulp Cells of a Patient with Cleidocranial Dysplasia in Serum- and Feeder-free Culture
    Mukasa, Hanae
    Yamasaki, Sachiko
    Taguchi, Yuki
    Simamoto, Akira
    Tahara, Hidetoshi
    Okamoto, Tetsuji
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2013, 49 : S44 - S44
  • [38] Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p. I2012T mutation
    Lin, Chin-Hsien
    Cheng, Yu-Che
    Lin, Han-I
    Ho, Ming-Ching
    Hsu, Yu-Hung
    Wen, Cheng-Hao
    Ko, Hui-Wen
    Lu, Huai-En
    Huang, Ching-Ying
    Hsieh, Patrick C. H.
    STEM CELL RESEARCH, 2017, 25 : 123 - 127
  • [39] Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation
    Schroeter, Friederike
    Sleegers, Kristel
    Cuyvers, Elise
    Bohndorf, Martina
    Wruck, Wasco
    Van Broeckhoven, Christine
    Adjaye, James
    STEM CELL RESEARCH, 2016, 17 (03) : 553 - 555
  • [40] Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report
    Hoefer, Richard A.
    Obiora, Chukwuemeka
    Azab, Basem
    Harden, Elizabeth A.
    Kessler, John F.
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2021, 83
12345